Literature DB >> 30913308

Microsatellite instability in endometrial cancer: New purpose for an old test.

Katherine C Kurnit1, Shannon N Westin1, Robert L Coleman1.   

Abstract

Entities:  

Keywords:  Lynch syndrome; endometrial cancer; immunotherapy; microsatellite instability; mismatch repair deficiency

Mesh：

Substances：

Year:  2019        PMID： 30913308      PMCID： PMC6763363          DOI： 10.1002/cncr.32058

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  59 in total

1.  Clinicopathological comparison of colorectal and endometrial carcinomas in patients with Lynch-like syndrome versus patients with Lynch syndrome.

Authors:  Jenny Mas-Moya; Beth Dudley; Randall E Brand; Darcy Thull; Nathan Bahary; Marina N Nikiforova; Reetesh K Pai
Journal:  Hum Pathol       Date:  2015-07-08       Impact factor: 3.466

2.  Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival.

Authors:  Casey M Cosgrove; David E Cohn; Heather Hampel; Wendy L Frankel; Dan Jones; Joseph P McElroy; Adrian A Suarez; Weiqiang Zhao; Wei Chen; Ritu Salani; Larry J Copeland; David M O'Malley; Jeffrey M Fowler; Ahmet Yilmaz; Alexis S Chassen; Rachel Pearlman; Paul J Goodfellow; Floor J Backes
Journal:  Gynecol Oncol       Date:  2017-07-11       Impact factor: 5.482

3.  Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas.

Authors:  M K McConechy; A Talhouk; H H Li-Chang; S Leung; D G Huntsman; C B Gilks; J N McAlpine
Journal:  Gynecol Oncol       Date:  2015-01-28       Impact factor: 5.482

4.  The clinical value of combination of immune checkpoint inhibitors in cancer patients: A meta-analysis of efficacy and safety.

Authors:  Yingcheng Wu; Hui Shi; Maorong Jiang; Mingyan Qiu; Keren Jia; Tianyue Cao; Yujuan Shang; Lili Shi; Kui Jiang; Huiqun Wu
Journal:  Int J Cancer       Date:  2017-08-30       Impact factor: 7.396

5.  Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer.

Authors:  Janice M Mehnert; Anshuman Panda; Hua Zhong; Kim Hirshfield; Sherri Damare; Katherine Lane; Levi Sokol; Mark N Stein; Lorna Rodriguez-Rodriquez; Howard L Kaufman; Siraj Ali; Jeffrey S Ross; Dean C Pavlick; Gyan Bhanot; Eileen P White; Robert S DiPaola; Ann Lovell; Jonathan Cheng; Shridar Ganesan
Journal:  J Clin Invest       Date:  2016-05-09       Impact factor: 14.808

6.  Consequences of universal MSI/IHC in screening ENDOMETRIAL cancer patients for Lynch syndrome.

Authors:  Brittany A L Batte; Amanda S Bruegl; Molly S Daniels; Kari L Ring; Katherine M Dempsey; Bojana Djordjevic; Rajyalakshmi Luthra; Bryan M Fellman; Karen H Lu; Russell R Broaddus
Journal:  Gynecol Oncol       Date:  2014-06-14       Impact factor: 5.482

7.  Impact of microsatellite instability (MSI) on survival in high grade endometrial carcinoma.

Authors:  Haitham Arabi; Hui Guan; Sanjeev Kumar; Michele Cote; Sudeshna Bandyopadhyay; Christopher Bryant; Jay Shah; Fadi W Abdul-Karim; Adnan R Munkarah; Rouba Ali-Fehmi
Journal:  Gynecol Oncol       Date:  2009-03-10       Impact factor: 5.482

8.  Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma.

Authors:  Destin Black; Robert A Soslow; Douglas A Levine; Carmen Tornos; Shirley C Chen; Amanda J Hummer; Faina Bogomolniy; Narciso Olvera; Richard R Barakat; Jeff Boyd
Journal:  J Clin Oncol       Date:  2006-03-20       Impact factor: 44.544

9.  Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinoma.

Authors:  Ippolito Modica; Robert A Soslow; Destin Black; Carmen Tornos; Noah Kauff; Jinru Shia
Journal:  Am J Surg Pathol       Date:  2007-05       Impact factor: 6.394

10.  Improvement of survival for non-small cell lung cancer over time.

Authors:  Wenjie Xia; Xinnian Yu; Qixing Mao; Wenying Xia; Anpeng Wang; Gaochao Dong; Bing Chen; Weidong Ma; Lin Xu; Feng Jiang
Journal:  Onco Targets Ther       Date:  2017-08-29       Impact factor: 4.147
View more
  4 in total

1.  Cost-effectiveness analysis of reflex testing for Lynch syndrome in women with endometrial cancer in the UK setting.

Authors:  Tristan M Snowsill; Neil A J Ryan; Emma J Crosbie; Ian M Frayling; D Gareth Evans; Chris J Hyde
Journal:  PLoS One       Date:  2019-08-30       Impact factor: 3.240

Review 2.  Lynch Syndrome and MSI-H Cancers: From Mechanisms to "Off-The-Shelf" Cancer Vaccines.

Authors:  Vladimir Roudko; Cansu Cimen Bozkus; Benjamin Greenbaum; Aimee Lucas; Robert Samstein; Nina Bhardwaj
Journal:  Front Immunol       Date:  2021-09-24       Impact factor: 7.561

3.  Endometrial Carcinoma: Molecular Cytogenetics and Transcriptomic Profile.

Authors:  Marta Brunetti; Ioannis Panagopoulos; Valeria Vitelli; Kristin Andersen; Tarjei S Hveem; Ben Davidson; Ane Gerda Z Eriksson; Pernille Kristina Bjerre Trent; Sverre Heim; Francesca Micci
Journal:  Cancers (Basel)       Date:  2022-07-20       Impact factor: 6.575

Review 4.  New Trends in the Detection of Gynecological Precancerous Lesions and Early-Stage Cancers.

Authors:  Jitka Holcakova; Martin Bartosik; Milan Anton; Lubos Minar; Jitka Hausnerova; Marketa Bednarikova; Vit Weinberger; Roman Hrstka
Journal:  Cancers (Basel)       Date:  2021-12-17       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.